Provided by Tiger Trade Technology Pte. Ltd.

Pulmonx Corp

2.26
-0.0400-1.74%
Post-market: 2.260.00000.00%19:30 EDT
Volume:610.20K
Turnover:1.38M
Market Cap:97.06M
PE:-1.96
High:2.35
Open:2.30
Low:2.20
Close:2.30
52wk High:2.89
52wk Low:1.13
Shares:42.95M
Float Shares:37.01M
Volume Ratio:1.33
T/O Rate:1.65%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1544
EPS(LYR):-1.3300
ROE:-88.87%
ROA:-22.10%
PB:2.48
PE(LYR):-1.70

Loading ...

Pulmonx Executives Quietly Unload a Wave of Shares in Coordinated Insider Moves

TIPRANKS
·
Jun 04

Pulmonx grants 84,300 RSUs to 17 new hires under inducement plan

Reuters
·
Jun 02

Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jun 02

Pulmonx publishes investor presentation on Zephyr valves for severe emphysema treatment

Reuters
·
May 05

Pulmonx Earnings Call: Margin Gains Amid Growth Pause

TIPRANKS
·
May 01

Lake Street Remains a Buy on Pulmonx (LUNG)

TIPRANKS
·
May 01

Pulmonx Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Apr 30

Analysts Conflicted on These Healthcare Names: Teladoc (TDOC), Madrigal Pharmaceuticals (MDGL) and Pulmonx (LUNG)

TIPRANKS
·
Apr 30

Pulmonx Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
Apr 30

Pulmonx backs FY26 revenue view $90M-$92M, consensus $90.87M

TIPRANKS
·
Apr 30

Pulmonx Q1 revenue falls, slightly beats estimates

Reuters
·
Apr 30

Pulmonx Q1 EPS $(0.33) Beats $(0.34) Estimate, Sales $20.586M Beat $20.432M Estimate

Benzinga Earnings
·
Apr 30

BRIEF-Pulmonx Q1 EPS USD -0.33

Reuters
·
Apr 30

Pulmonx Corp - Sees FY 2026 Cash, Cash Equivalents, and Securities to Decrease by $23 Mln

THOMSON REUTERS
·
Apr 30

Pulmonx Outlook FY Gross Margin 75%

THOMSON REUTERS
·
Apr 30

Pulmonx Outlook FY Revenue USD 90-92 Million

THOMSON REUTERS
·
Apr 30

Pulmonx Reports First Quarter 2026 Financial Results

GlobeNewswire
·
Apr 30

Pulmonx Corp expected to post a loss of 33 cents a share - Earnings Preview

Reuters
·
Apr 28

Pulmonx to Report First Quarter 2026 Financial Results on April 29, 2026

GlobeNewswire
·
Apr 16

Pulmonx Insiders Forfeit On 14% Gains After Selling Stock

Simply Wall St.
·
Apr 05